S
SCI Pharmtech Inc
TWSE:4119
SCI Pharmtech Inc
TWSE:4119
Price:
83
TWD
-0.12%
Market Closed
Market Cap:
9.9B
TWD
SCI Pharmtech Inc
Tax Provision
|
SCI Pharmtech Inc
Tax Provision Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Tax Provision | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
S
|
SCI Pharmtech Inc
TWSE:4119
|
Tax Provision
-NT$100m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
7%
|
CAGR 10-Years
-6%
|
|
|
Y
|
YungShin Global Holding Corp
TWSE:3705
|
Tax Provision
-NT$388.5m
|
CAGR 3-Years
-17%
|
CAGR 5-Years
-12%
|
CAGR 10-Years
-7%
|
|
|
Formosa Laboratories Inc
TWSE:4746
|
Tax Provision
-NT$155.2m
|
CAGR 3-Years
-50%
|
CAGR 5-Years
-25%
|
CAGR 10-Years
-11%
|
|
|
ScinoPharm Taiwan Ltd
TWSE:1789
|
Tax Provision
-NT$90.8m
|
CAGR 3-Years
-22%
|
CAGR 5-Years
-3%
|
CAGR 10-Years
-5%
|
|
|
Lotus Pharmaceutical Co Ltd
TWSE:1795
|
Tax Provision
-NT$1B
|
CAGR 3-Years
-29%
|
CAGR 5-Years
-59%
|
CAGR 10-Years
-34%
|
|
|
Standard Chem & Pharm Co Ltd
TWSE:1720
|
Tax Provision
-NT$314.9m
|
CAGR 3-Years
-26%
|
CAGR 5-Years
-21%
|
CAGR 10-Years
-18%
|
|
SCI Pharmtech Inc
Glance View
SCI Pharmtech Corp. is engaged in the biotechnology and medical care industry. The company is headquartered in Taoyuan, Taoyuan. The company went IPO on 2002-08-12. The firm's main products include APIs, API intermediates and special and precision chemicals. The firm distributes its products in domestic market and to overseas markets, including Europe, the Americas, the rest areas of Asia and others
Intrinsic Value
50.21
TWD
Overvaluation 40%
S
See Also
What is SCI Pharmtech Inc's Tax Provision?
Tax Provision
-100m
TWD
-100m
TWD
Based on the financial report for Sep 30, 2024, SCI Pharmtech Inc's Tax Provision amounts to -100m TWD.
What is SCI Pharmtech Inc's Tax Provision growth rate?
Tax Provision CAGR 10Y
-6%
-6%
Over the last year, the Tax Provision growth was -5%.
You don't have any saved screeners yet